Scarica l'app Stockscreener
92.63
0.08%
-0.07
Dopo l'orario di chiusura:
92.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$92.70
Aprire:
$92.6
Volume 24 ore:
217.42K
Relative Volume:
0.67
Capitalizzazione di mercato:
$3.04B
Reddito:
$2.32B
Utile/perdita netta:
$82.93M
Rapporto P/E:
36.76
EPS:
2.52
Flusso di cassa netto:
$203.54M
1 W Prestazione:
-0.12%
1M Prestazione:
+0.68%
6M Prestazione:
-4.02%
1 anno Prestazione:
+0.51%
Intervallo 1D:
$92.44
$93.25
Intervallo di 1 settimana:
$92.14
$93.25
Portata 52W:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Nome
Amedisys Inc
Settore
Industria
Telefono
(225) 292-2031
Indirizzo
3854 AMERICAN WAY, BATON ROUGE, LA
Confronta AMED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
92.63 | 3.04B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
345.55 | 84.29B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.90 | 14.41B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
152.97 | 13.37B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
134.50 | 13.18B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
187.90 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Downgrade | Truist | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Iniziato | Barclays | Equal Weight |
| 2022-10-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Downgrade | UBS | Neutral → Sell |
| 2022-06-29 | Iniziato | Stifel | Hold |
| 2022-06-21 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Aggiornamento | UBS | Sell → Neutral |
| 2022-02-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Reiterato | Credit Suisse | Outperform |
| 2022-02-25 | Reiterato | Oppenheimer | Outperform |
| 2022-02-25 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-02-25 | Reiterato | Raymond James | Outperform |
| 2022-02-25 | Reiterato | Truist | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Sell |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-10 | Reiterato | The Benchmark Company | Buy |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-08-20 | Ripresa | Barclays | Overweight |
| 2020-07-30 | Reiterato | The Benchmark Company | Buy |
| 2020-06-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Iniziato | Credit Suisse | Outperform |
| 2019-11-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Ripresa | Stephens | Equal-Weight |
| 2019-09-17 | Iniziato | Deutsche Bank | Buy |
| 2019-05-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Iniziato | Barclays | Equal Weight |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-10-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Reiterato | Mizuho | Buy |
| 2017-11-02 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Iniziato | BofA/Merrill | Neutral |
Mostra tutto
Amedisys Inc Borsa (AMED) Ultime notizie
Lobbying Update: $50,000 of AMEDISYS HOME HEALTH AND HOSPICE CARE lobbying was just disclosed - Nasdaq
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report? - Yahoo Finance
Amedisys’ home health volume increases by 5% for Q4 2020 as profits soar by 63% - McKnight's Senior Living
Oppenheimer moving to Perform from Not Rated on Amedisys - TipRanks
US Bancorp DE Boosts Holdings in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Raymond James maintains Amedisys stock Market Perform rating By Investing.com - Investing.com Canada
Raymond James maintains Amedisys stock Market Perform rating - Investing.com
Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Bank of New York Mellon Corp - Defense World
Mutual of America Capital Management LLC Has $1.57 Million Stake in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Amedisys, Inc. (NASDAQ:AMED) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Amedisys, Inc. to Host Earnings Call - ACCESS Newswire
Amedisys chief accounting officer sells $187,833 in stock By Investing.com - Investing.com South Africa
Amedisys chief accounting officer sells $187,833 in stock - Investing.com
DOJ Fights Bid To Pause Piece Of Amedisys Merger Case - Law360
Amedisys (NASDAQ:AMED) Receives “Equal Weight” Rating from Stephens - Defense World
Amedisys motion to separate Section 7A claim should be denied, US DOJ says - MLex
Hospice Services Market Projected To Witness Substantial Growth, 2025-2032: AccentCare, Curo Health Services, - EIN News
Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Principal Financial Group Inc. - Defense World
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises - Yahoo Finance
William Blair Has Negative Estimate for Amedisys Q1 Earnings - MarketBeat
Research Analysts Offer Predictions for Amedisys Q1 Earnings - Defense World
Decoding Amedisys Inc (AMED): A Strategic SWOT Insight - GuruFocus.com
Amedisys Reports 2024 Financial Results Amid Merger Plans - TipRanks
Amedisys (NASDAQ:AMED) Posts Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Amedisys (NASDAQ:AMED) Issues Quarterly Earnings Results - MarketBeat
Amedisys Hold Rating: Mixed Performance and Cost Pressures Amid Regulatory Uncertainties - TipRanks
Amedisys Reports Home Health Care Growth Amid Shadow Of DOJ-UHG Lawsuit - Home Health Care News
Amedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or later - MSN
Amedisys Sees Hospice Growth as DOJ-UnitedHealth Group Lawsuit Looms - Hospice News
Amedisys tells SEC several states have enacted ‘mini-Hart-Scott-Rodino laws’ - MLex
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
AMEDISYS INC SEC 10-K Report - TradingView
Amedisys: Q4 Earnings Snapshot - mySA
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates - Yahoo Finance
Amedisys Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Amedisys Reports Q4 2024 Financial Results Amid Merger Plans - TipRanks
Earnings Flash (AMED) AMEDISYS INC. Reports Q4 Adjusted EPS $0.96, vs. FactSet Est of $1.05 - Marketscreener.com
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results - The Manila Times
Amedisys Earnings: How $66M in Merger Expenses Shaped Their Bottom Line - StockTitan
Homecare Rehabilitation Service Market Projected To Witness Substantial Growth, 2025-2032: Genesis HealthCare, - EIN News
UnitedHealth-Amedisys referral to magistrate judge sparks settlement hopes - MLex
UnitedHealth-Amedisys case with US DOJ referred to judge for settlement talks - MLex
Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by Rhumbline Advisers - Defense World
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down - MSN
US probes UnitedHealth's Medicare billing practices, WSJ reports - ET HealthWorld
Short Interest in Amedisys, Inc. (NASDAQ:AMED) Rises By 7.1% - MarketBeat
ABC Arbitrage SA Invests $2.52 Million in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
United Health-Amedisys trial in US DOJ challenge 'tentatively' set for Oct. 27 - MLex
AMED: 3 Up-and-Coming Healthcare Providers Enhancing Patient Care - StockNews.com
Amedisys Inc Azioni (AMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):